A Living Archive of High-risk Lymphoma

Area of Science:

• Hematology
• Oncology
• Cancer Biology

Background:

• Aggressive large B-cell lymphoma (LBCL) poses significant treatment challenges.
• Understanding therapeutic resistance mechanisms is crucial for improving patient outcomes.

Purpose of the Study:

• To establish a comprehensive, publicly available repository of patient-derived xenograft (PDX) models for aggressive LBCL.
• To link these PDX models with detailed clinical and molecular data.

Main Methods:

• Generation of PDX models from LBCL patient specimens.
• Collection of extensive clinical treatment histories, including responses to modern therapies.
• Comprehensive molecular and transcriptional profiling of the tumors.

Main Results:

• A curated repository of PDX models representing diverse LBCL subtypes and treatment exposures.
• Detailed characterization of tumor specimens, including genetic and gene expression data.
• Establishment of a link between tumor biology and clinical outcomes.

Conclusions:

• The developed resource provides a powerful platform for investigating tumor cell-intrinsic mechanisms of drug resistance and sensitivity.
• Facilitates preclinical studies of novel therapeutic strategies in aggressive LBCL.
• Enables deeper understanding of LBCL heterogeneity and treatment response.